Indian drug major Sun pharmaceuticals has secured tentative approval from the United States Food and Drugs administration for the generic version of gleeven, used to treat chronic myeloid leukaemia. The drug will be available in two strengths of 100 mg and 400 mg and the market size for them is estimated at nearly $900 million.crackcrack

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×